68 related articles for article (PubMed ID: 17721792)
21. Cancer-associated retinopathy (CAR) with electronegative ERG: a case report.
Goetgebuer G; Kestelyn-Stevens AM; De Laey JJ; Kestelyn P; Leroy BP
Doc Ophthalmol; 2008 Jan; 116(1):49-55. PubMed ID: 17721792
[TBL] [Abstract][Full Text] [Related]
22. Typical electronegative electroretinography and nyctalopia as a presenting feature of systemic malignant melanoma.
Vercio A; Chalam KV; Winter T
Int Med Case Rep J; 2019; 12():265-276. PubMed ID: 31496836
[TBL] [Abstract][Full Text] [Related]
23. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
24. A case of paraneoplastic retinopathy.
Oohira A; Tamaki Y; Nagahara K; Nakanishi N
Jpn J Ophthalmol; 1993; 37(1):28-31. PubMed ID: 8320862
[TBL] [Abstract][Full Text] [Related]
25. Clinical and immunological characterization of paraneoplastic retinopathy.
Makiyama Y; Kikuchi T; Otani A; Oishi A; Guo C; Nakagawa S; Ogino K; Kojima H; Kurimoto M; Yoshimura N
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5424-31. PubMed ID: 23860756
[TBL] [Abstract][Full Text] [Related]
26. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
[TBL] [Abstract][Full Text] [Related]
27. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
28. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
Dot C; Guigay J; Adamus G
Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
30. Neuro-ophthalmology and paraneoplastic syndromes.
Bataller L; Dalmau J
Curr Opin Neurol; 2004 Feb; 17(1):3-8. PubMed ID: 15090871
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic syndromes associated with visual loss.
Ling CP; Pavesio C
Curr Opin Ophthalmol; 2003 Dec; 14(6):426-32. PubMed ID: 14615650
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic retinopathies and optic neuropathies.
Chan JW
Surv Ophthalmol; 2003; 48(1):12-38. PubMed ID: 12559325
[TBL] [Abstract][Full Text] [Related]
33. Non-cancerous ophthalmic clues to non-ocular cancer.
Robertson DM
Surv Ophthalmol; 2002; 47(5):397-430. PubMed ID: 12431692
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
[TBL] [Abstract][Full Text] [Related]
35. Nature of the cone ON-pathway dysfunction in melanoma-associated retinopathy.
Alexander KR; Barnes CS; Fishman GA; Milam AH
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1189-97. PubMed ID: 11923265
[TBL] [Abstract][Full Text] [Related]
36. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
Keltner JL; Thirkill CE; Yip PT
J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
[TBL] [Abstract][Full Text] [Related]
37. Melanoma-associated retinopathy: does autoimmunity prolong survival?
Chan C; O'Day J
Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
[TBL] [Abstract][Full Text] [Related]
38. Retinopathies associated with antiretinal antibodies.
Hooks JJ; Tso MO; Detrick B
Clin Diagn Lab Immunol; 2001 Sep; 8(5):853-8. PubMed ID: 11527791
[No Abstract] [Full Text] [Related]
39. The incidence of negative ERG in clinical practice.
Koh AH; Hogg CR; Holder GE
Doc Ophthalmol; 2001 Jan; 102(1):19-30. PubMed ID: 11475363
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
